Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

No need for 60%-plus discounts on Repatha, Amgen says, rolling out real-world data as backup

fiercepharmaAugust 24, 2017

Tag: Amgen , cholesterol drug , cardiovascular outcomes

PharmaSources Customer Service